Evidence map›Paper›PMID 28750643›Full record

ArticleLipids in health and disease2017

Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas.

Csaba Csonka, Tamás Baranyai, László Tiszlavicz, Hedvig Fébel, Gergő Szűcs, Zoltán V Varga, Márta Sárközy, László G Puskás, Otilia Antal, Andrea Siska and 4 more

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Effect ofEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
  12. The incretin enhancer, sitagliptin, exacerbates expression of hepatic inflammatory markers in rats fed a high-cholesterol diet.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Csaba CsonkaMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary.
Tamás BaranyaiMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary.
László TiszlaviczDepartment of Pathology, University of Szeged, Szeged, Hungary.
Hedvig FébelResearch Institute for Animal Breeding, Nutrition and Meat Science, Herceghalom, Szeged, Hungary.
Gergő SzűcsMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary.
Zoltán V VargaMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary.
Márta SárközyMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary.
László G PuskásInstitute of Genetics, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary.
Otilia AntalInstitute of Genetics, Biological Research Center, Hungarian Academy of Sciences, Szeged, Hungary.
Andrea SiskaDepartment of Laboratory Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Imre FöldesiDepartment of Laboratory Medicine, Faculty of Medicine, University of Szeged, Szeged, Hungary.
Péter FerdinandyDepartment of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.
László Czakó1st Department of Internal Medicine, University of Szeged, Szeged, Hungary.
Tamás CsontMetabolic Diseases and Cell Signaling Research Group, Department of Biochemistry, University of Szeged, Dóm tér 9, Szeged, H-6720, Hungary. csont.tamas@med.u-szeged.hu.
University of Szeged · HUSemmelweis University · HUHungarian Academy of Sciences · HUInstitute of Genetics · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLipid accumulation in the liver and pancreas is primarily caused by combined hyperlipidemia. However, the effect of isolated hypercholesterolemia without hypertriglyceridemia is not fully described. Therefore, our aim was to investigate whether hypercholesterolemia alone leads to alterations both in hepatic and pancreatic lipid panel and histology in rats.

methodsMale Wistar rats were fed with 2% cholesterol +0.25% cholate-supplemented diet or standard chow for 12 weeks. Blood was collected at weeks 0, 4, 8 and 12 to measure serum cholesterol and triglyceride levels. At week 12, both the pancreas and the liver were isolated for further histological and biochemical analysis. Hepatic and plasma fatty acid composition was assessed by gas chromatography. Expression of mRNA of major enzymes involved in saturated/unsaturated fatty acid synthesis was analyzed by qPCR. In separate experiments serum enzyme activities and insulin levels were measured at week 9.

resultsAt week 12, rats fed with 2% cholesterol +0.25% cholate-supplemented diet were characterized by elevated serum cholesterol (4.09 ± 0.20 vs. 2.89 ± 0.22 mmol/L, *p < 0.05) while triglyceride (2.27 ± 0.05 vs. 2.03 ± 0.03 mmol/L) and glucose levels (5.32 ± 0.14 vs. 5.23 ± 0.10 mmol/L) remained unchanged. Isolated hypercholesterolemia increased hepatic lipid accumulation, hepatic cholesterol (5.86 ± 0.22 vs. 1.60 ± 0.15 ng/g tissue, *p < 0.05) and triglyceride contents (19.28 ± 1.42 vs. 6.78 ± 0.71 ng/g tissue, *p < 0.05), and hepatic nitrotyrosine level (4.07 ± 0.52 vs. 2.59 ± 0.31 ng/mg protein, *p < 0.05). The histology and tissue lipid content of the pancreas was not affected. Serum total protein level, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities remained unchanged in response to isolated hypercholesterolemia while serum alkaline phosphatase activity (ALP) significantly increased. Plasma insulin levels did not change in response to isolated hypercholesterolemia suggesting an intact endocrine function of the pancreas. Isolated hypercholesterolemia caused a significantly increased hepatic and serum fatty acid level associated with a marked alteration of fatty acid composition. Hepatic expression of Δ9-desaturase (SCD1) was increased 4.92×, while expression of Δ5-desaturase and Δ6-desaturase were decreased (0.447× and 0.577×, respectively) due to isolated hypercholesterolemia.

conclusionsIsolated hypercholesterolemia leads to hepatic steatosis and marked alterations in the hepatic lipid profile without affecting the pancreas. Altered fatty acid profile might mediate harmful effects of cholesterol in the liver.

Indexed as

AnimalsBlood GlucoseBody WeightCholesterolEnzymesFatty AcidsFatty LiverHypercholesterolemiaInsulinLiverMaleNitrosative StressOrgan SizeOxidative StressPancreasRats, Wistar3-nitrotyrosineBlood GlucoseCholesterolEnzymesFatty AcidsInsulinRNA, MessengerTriglyceridesTyrosineFatty acid desaturase (FADS)Isolated hypercholesterolemiaLipid dropletsLipidomicsLipotoxicityNon-alcoholic fatty liver diseaseStearoyl-coenzyme a desaturase (SCD)

Identifiers

PMID28750643
PMCPMC5532767
OpenAlexW2737613623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.